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o We Need
ew Echocardiographic
rognosticators for the
anagement of Heart
ailure Patients?*
tephane Lafitte, MD, PHD
essac, France
ardiac insufficiency is a major public health problem.
hanks to progress made in the field of heart failure
harmacotherapy during the last 3 decades, mortality rates
ave decreased by 30% (1). However, despite perfectly
efined recommendations concerning heart failure drug
reatment (2,3), follow-up remains insufficient (4) for rea-
ons relating both to poor drug tolerability or incompatibil-
ty and suboptimal prescription practices (5). It has been
hown that, for heart failure patients, better adherence to
ecommendations allows the reduction of cardiovascular
vents (6). To help the prescriber, clinical risk stratification
See page 618
an be improved using biological parameters, such as brain
atriuretic peptide (7), functional tests (oxygen consump-
ion per minute) (8), or cardiac imaging, that will influence
eart failure patient management by identifying the most
everely ill patients.
chocardiographic risk evaluation and deformation
nalysis. Because of its accessibility, reliability, and low
rice, echocardiography has been the subject of numerous
ublications on heart failure patient risk evaluation. Estab-
ished criteria may associate left (9,10) and right (11,12)
entricular function parameters, mitral insufficiency quanti-
cation (13), and an asynchrony assessment (14).
In this issue of the Journal, the study by Cho et al. (15)
dentified an additional prognostic factor in heart failure
atients using a recent technique that enabled the echocar-
iographic analysis of myocardial deformations. This new
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.t
From the Cardiologic Hospital and Inserm 828, Bordeaux University Hospital
enter, Pessac, France.pproach to myocardial contraction measurement allows
entricular function analysis by distinguishing radial, longi-
udinal, and circumferential contraction components on the
asis of the orientation of myocyte fibers. Study results show
hat this technique also boasts high feasibility and reliability
ates as compared with common echocardiographic mea-
urements (longitudinal and circumferential strain feasibili-
ies: 88% to 92%, variabilities: 3.6% to 6.3%). It should be
oted that these reproducibility data are comparable to
hose reported in literature, regardless of the cardiopathy
nvestigated (16–18). In the analysis, the authors demon-
trated that the circumferential deformation parameter was
stronger predictor of cardiovascular events than both
onventional systolic or diastolic parameters and the longi-
udinal deformation parameter.
ongitudinal versus circumferential strain. The supe-
iority of circumferential deformation merits a more
rofound explanation so as not to underestimate the
ertinence of the longitudinal component. As Cho et al.
15) reported, the longitudinal deformation component
ainly refers to the exploration of the contraction caused by
ubendocardial and subepicardial fibers, which have an
blique-longitudinal orientation and curl up around the
eart’s longitudinal axis in a double helix. Contrarily,
ircumferential deformation originates in the mid-wall lay-
rs, where transversally oriented fibers are situated. These
bers are responsible for myocardial thickening, also called
adial contraction or deformation. Studies based on tissue
oppler, and more recently deformation analysis, show that
egardless of the physiopathological model, the initial de-
ormation of ventricular contraction affects the longitudinal
xis, whereas radial function is preserved in the early phase
17–20). The typical example of this is aortic stenosis, the
arly and isolated longitudinal function alteration of which
as described 30 years ago by Dumesnil et al. (21) and
onfirmed recently through deformation analysis (22). This
arly unidirectional contraction anomaly likely has a multi-
actorial origin, including a greater longitudinal fiber sus-
eptibility to myocardial ischemia, elevated parietal con-
traints, and ventricular remodeling. In the second phase of
entricular dysfunction progression, the initially compensat-
ng mid-wall fibers alter their contraction, leading first to
he deterioration of circumferential and then radial defor-
ations (23). It is not surprising that these 2 deformation
omponents are a stronger prognostic factor than the longitu-
inal deformation, which is a less severe but earlier visible
arker of myocardial contraction alteration.
ultiparametric approach. The question of multiplying
arameters and their clinical application is legitimate. Tak-
ng into account the report by Cho et al. (15), which favors
specific criterion over others, logic would suggest focusing
n this criterion. However, each echocardiographic criterion
as its limitations, including feasibility, diagnostic precision,
nd reproducibility. Deformation analysis based on speckle
racking is not an exception to this rule, and the quality of
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Heart Failure and Echocardiography August 11, 2009:625–7nformation obtained is highly dependent on the echocar-
iographic window. In addition to the imperfect reliability
ate, longitudinal deformation obtained during apical data
cquisition is more reproducible than radial or circumferen-
ial deformation obtained during parasternal data acquisi-
ion. It should be noted that the combination of comple-
entary clinical, biological, and echocardiographic criteria
llows the circumvention of analysis limitations, and this
onvergence enables the best possible risk evaluation in
eart failure patients.
The principal limitation of the work of Cho et al. (15),
hich proposes a multicriteria echocardiographic analysis, is
hat it lacks comparisons with right ventricular function
arameters. Considering the strong clinical impact of these
omponents on the prognosis of heart failure patients (24),
t is conceivable that the statistical weight of deformation
arameters would have been diminished had Cho et al. (15)
aken them into account. The difficulty in obtaining right
entricular ejection fraction limits the use of this echo-
ardiographic parameter, though this could be sur-
ounted by applying the tissue Doppler imaging crite-
ion to the tricuspid annulus (12).
Table 1 summarizes the principal echocardiographic cri-
eria, which have been shown to be prognosticators for heart
ailure patients, and their threshold values.
onclusions. Echocardiography has a position of choice
n the follow-up of heart failure patients, especially for
he stratification of patient risk. Regardless of any single
riterion’s weight, the clinical approach needs to be
ultiparametric, as the sum of different positive param-
ters permits an improved patient risk diagnosis (25,26).
his approach allows high-risk patients to be identified
oninvasively and may provide guidance for special pa-
ient treatment with intensified monitoring and opti-
ized drug therapy.
eprint requests and correspondence: Dr. Stephane Lafitte,
ervice des Echocardiographies, Hopital Cardiologique, Avenue
agellan, Pessac, Gironde 33600, France. E-mail: stephane.lafitte@
rinciple Echocardiographicognosticat rs for He rt Failure Patients
Table 1 P inciple Echo ardiogr phicPrognosticators for Heart Failure Patients
Parameter Threshold Value
LV ejection fraction, % 32
LV TDI S-wave, cm/s 5
dP/dt of mitral regurgitation jet, mm Hg/s 600
Right ventricular TDI S-wave, cm/s 11.5
Deceleration time, ms 150
E/Ea 15
Ischemic mitral regurgitation, EROA, mm2 20
Pulmonary pressure, mm Hg 40
Circumferential strain, % 10.7
ROA  effective regurgitation orifice area; LV  left ventricular; TDI  tissue Doppler imaging.hu-bordeaux.fr.EFERENCES
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